Status:
COMPLETED
Clinical Evaluation of BackStop in Patients Undergoing Intraureteric Stone Lithotripsy
Lead Sponsor:
Pluromed, Inc.
Conditions:
Renal Calculi
Kidney Stones
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this clinical study is to evaluate BackStop, a polymer-based device that is intended to be used during ureteroscopic lithotripsy to prevent retrograde stone migration. It is a water sol...
Eligibility Criteria
Inclusion
- Patient with a solitary, radio-opaque ureteral stone in the proximal ureter.
- Clinical indication for treatment by ureteroscopic lithotripsy.
- Minimum 18 years old (or any institutional age limits for participation in clinical study).
- Patients must be willing and able to participate in any follow-up visits, as required.
- Patients must provide informed consent.
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00893282
Start Date
February 1 2008
End Date
December 1 2008
Last Update
May 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University Health Center
Montreal, Quebec, Canada, H3A1A1